B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells.

[1]  Jianhui Sun,et al.  Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis , 2022, Frontiers in Surgery.

[2]  Lin Li,et al.  The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies , 2022, International journal of molecular sciences.

[3]  J. Ferlay,et al.  The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study , 2022, EClinicalMedicine.

[4]  A. Niapour,et al.  Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis , 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  H. Hsieh,et al.  Molecular mechanism of therapeutic approaches for human gastric cancer stem cells , 2022, World journal of stem cells.

[6]  Zhongwei Lv,et al.  Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma , 2022, Technology in cancer research & treatment.

[7]  Michael R Hamblin,et al.  The role of SOX family transcription factors in gastric cancer. , 2021, International journal of biological macromolecules.

[8]  Ji-gang Zhang,et al.  Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents , 2021, Signal Transduction and Targeted Therapy.

[9]  B. Liu,et al.  Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway , 2021, BMC cancer.

[10]  Q. Dong,et al.  Targeting BMI-1-mediated epithelial–mesenchymal transition to inhibit colorectal cancer liver metastasis , 2020, Acta pharmaceutica Sinica. B.

[11]  Caigang Liu,et al.  HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients , 2020, International journal of medical sciences.

[12]  Yurong Song,et al.  PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers , 2020, Cell Death & Disease.

[13]  J. Lang,et al.  EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer , 2020, BMC Cancer.

[14]  M. Ashrafizadeh,et al.  PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation , 2020, Biomedicines.

[15]  R. Mohammadinejad,et al.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects , 2020, Biology.

[16]  Y. Liu,et al.  BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor , 2020, Oncology reports.

[17]  Dexi Chen,et al.  The significance of exosomes in the development and treatment of hepatocellular carcinoma , 2020, Molecular Cancer.

[18]  Do-Hee Kim,et al.  Nrf2-induced reductive stress favours self-renewal of breast cancer stem-like cells via the FoxO3a-Bmi-1 axis. , 2020, Antioxidants & redox signaling.

[19]  S. Han,et al.  Ellagic Acid Inhibits Extracellular Acidity-Induced Invasiveness and Expression of COX1, COX2, Snail, Twist 1, and c-myc in Gastric Carcinoma Cells , 2019, Nutrients.

[20]  Harlan R. Barker,et al.  Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways , 2019, Cells.

[21]  P. Hou,et al.  miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway. , 2019, Pathology, research and practice.

[22]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[23]  G. Deng,et al.  MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma. , 2018, Molecular pharmaceutics.

[24]  Ziwei Wang,et al.  SOX4 contributes to TGF-β-induced epithelial–mesenchymal transition and stem cell characteristics of gastric cancer cells , 2017, Genes & diseases.

[25]  Jianglin Wang,et al.  Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16Ink4A/p14ARF gene expressions: An in vivo and in vitro study. , 2017, Pathology, research and practice.

[26]  D. Yoon,et al.  MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells , 2017, Oncotarget.

[27]  Lei Wang,et al.  [Research Advances of Side Population Cells in Multiple Myeloma -Review]. , 2017, Zhongguo shi yan xue ye xue za zhi.

[28]  Yadong Wang,et al.  Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1 , 2017, Molecular carcinogenesis.

[29]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[30]  Wei-wei Yu,et al.  The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer , 2017, Oncotarget.

[31]  Jie Song,et al.  USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein , 2017, Oncotarget.

[32]  Yan Yan,et al.  BMI-1 Promotes Self-Renewal of Radio- and Temozolomide (TMZ)-Resistant Breast Cancer Cells , 2017, Reproductive Sciences.

[33]  C. Lian,et al.  Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma. , 2017, Oncology reports.

[34]  Na-Yu Chia,et al.  Molecular classification of gastric cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  K. Nan,et al.  Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study , 2016, Oncotarget.

[36]  Jian-ning Chen,et al.  Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance , 2016, Gastric Cancer.

[37]  Ruiwen Zhang,et al.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications , 2015, Medicinal research reviews.

[38]  K. Nan,et al.  BMI-1, a promising therapeutic target for human cancer. , 2015, Oncology letters.

[39]  Xiaofeng Zhou,et al.  Bmi1 Drives Stem-Like Properties and is Associated with Migration, Invasion, and Poor Prognosis in Tongue Squamous Cell Carcinoma , 2015, International journal of biological sciences.

[40]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[41]  Xiaoming Yu,et al.  Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells , 2014, Oncology letters.

[42]  Jie Cheng,et al.  Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer , 2014, Laboratory Investigation.

[43]  Yanhong Zhou,et al.  [Side population cells and progress in cancer stem cell research]. , 2014, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[44]  D. Simeone,et al.  Bmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma , 2013, PloS one.

[45]  C. Tzeng,et al.  Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer. , 2013, Cancer research.

[46]  B. Han,et al.  IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance , 2013, Tumor Biology.

[47]  M. Tetzlaff,et al.  miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. , 2012, The American journal of pathology.

[48]  PhD Kay Washington MD.  7th Edition of the AJCC Cancer Staging Manual: Stomach , 2010, Annals of Surgical Oncology.

[49]  H. Beppu,et al.  Repulsive Guidance Molecule RGMa Alters Utilization of Bone Morphogenetic Protein (BMP) Type II Receptors by BMP2 and BMP4* , 2007, Journal of Biological Chemistry.

[50]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[51]  Anton Berns,et al.  Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.